Roch Doliveux

Member of the Strategic Advisory Board

Roch is the current chairman of Oxford Biomedica, Pierre Fabre Group and GLG Institute as well as board member of UCB and Stryker. Roch was CEO and Chairman of the Executive Committee of UCB, CEO of Pierre Fabre Pharmaceuticals and President of Schering-Plough International (now Merck and Co.). Roch holds an MBA from INSEAD and a doctorate from École Nationale Vétérinaire d'Alfort.